Clinical Trials Browser

Phase 1 × Leukemia, Biphenotypic, Acute × Inotuzumab Ozogamicin × Clear all

NCT01925131 2023-05-03

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Phase 1 Completed

50 enrolled 14 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma